JP2023520205A5 - - Google Patents
Info
- Publication number
- JP2023520205A5 JP2023520205A5 JP2022559575A JP2022559575A JP2023520205A5 JP 2023520205 A5 JP2023520205 A5 JP 2023520205A5 JP 2022559575 A JP2022559575 A JP 2022559575A JP 2022559575 A JP2022559575 A JP 2022559575A JP 2023520205 A5 JP2023520205 A5 JP 2023520205A5
- Authority
- JP
- Japan
- Prior art keywords
- immune cells
- effector immune
- mhc class
- effector
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076879A JP2025107358A (ja) | 2020-04-08 | 2025-05-02 | 細胞 |
| JP2025082745A JP2025122064A (ja) | 2020-04-08 | 2025-05-16 | 細胞 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005216.3 | 2020-04-08 | ||
| GBGB2005216.3A GB202005216D0 (en) | 2020-04-08 | 2020-04-08 | Cell |
| PCT/GB2021/050862 WO2021205172A1 (en) | 2020-04-08 | 2021-04-08 | Cell |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076879A Division JP2025107358A (ja) | 2020-04-08 | 2025-05-02 | 細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520205A JP2023520205A (ja) | 2023-05-16 |
| JP2023520205A5 true JP2023520205A5 (cg-RX-API-DMAC7.html) | 2024-02-21 |
Family
ID=70768915
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559575A Pending JP2023520205A (ja) | 2020-04-08 | 2021-04-08 | 細胞 |
| JP2025076879A Pending JP2025107358A (ja) | 2020-04-08 | 2025-05-02 | 細胞 |
| JP2025082745A Pending JP2025122064A (ja) | 2020-04-08 | 2025-05-16 | 細胞 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076879A Pending JP2025107358A (ja) | 2020-04-08 | 2025-05-02 | 細胞 |
| JP2025082745A Pending JP2025122064A (ja) | 2020-04-08 | 2025-05-16 | 細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20230338534A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4132566A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2023520205A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115348869A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021251459A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174659A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202005216D0 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021205173A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113226340A (zh) | 2018-11-26 | 2021-08-06 | 恩卡尔塔公司 | 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途 |
| KR20210137085A (ko) | 2019-03-05 | 2021-11-17 | 엔카르타, 인크. | Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도 |
| KR20240004937A (ko) | 2021-05-05 | 2024-01-11 | 이매틱스 바이오테크놀로지스 게엠베하 | Bma031 항원 결합 폴리펩타이드 |
| CN117511882A (zh) * | 2022-08-03 | 2024-02-06 | 浙江大学医学院附属第一医院 | 一种通用型免疫效应细胞及其制备方法和应用 |
| CN115747166B (zh) * | 2022-10-13 | 2024-12-06 | 上海怡豪生物科技有限公司 | 一种通用型car-t细胞及其制备方法与应用 |
| EP4608856A1 (en) * | 2022-10-27 | 2025-09-03 | CARGO Therapeutics, Inc. | Compositions and methods for improved immunotherapies |
| JP2026525671A (ja) * | 2023-07-26 | 2026-07-31 | ビーアールエル メディシン (シャンハイ) カンパニー リミテッド | 疾患を治療するための方法及び組成物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7381803B1 (en) | 1992-03-27 | 2008-06-03 | Pdl Biopharma, Inc. | Humanized antibodies against CD3 |
| JP2002541845A (ja) | 1999-04-16 | 2002-12-10 | セルテック セラピューティックス リミテッド | 合成膜貫通成分 |
| EP1667717A2 (en) | 2003-09-09 | 2006-06-14 | GPC Biotech AG | Therapeutic human anti-mhc class ii antibodies and their uses |
| GB201206559D0 (en) | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| RU2744046C2 (ru) | 2014-03-05 | 2021-03-02 | Отолус Лимитед | ХИМЕРНЫЙ АНТИГЕННЫЙ РЕЦЕПТОР (CAR) С АНТИГЕНСВЯЗЫВАЮЩИМИ ДОМЕНАМИ К КОНСТАНТНОЙ ОБЛАСТИ β Т-КЛЕТОЧНОГО РЕЦЕПТОРА |
| GB201405845D0 (en) | 2014-04-01 | 2014-05-14 | Ucl Business Plc | Signalling system |
| BR112017000939A2 (pt) * | 2014-07-21 | 2017-11-14 | Novartis Ag | tratamento de câncer usando um receptor antigênico quimérico de cll-1 |
| GB201415347D0 (en) | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Signalling system |
| GB201501936D0 (en) | 2015-02-05 | 2015-03-25 | Ucl Business Plc | Signalling system |
| GB201503742D0 (en) | 2015-03-05 | 2015-04-22 | Ucl Business Plc | Chimeric antigen receptor |
| GB201504840D0 (en) | 2015-03-23 | 2015-05-06 | Ucl Business Plc | Chimeric antigen receptor |
| TWI700298B (zh) * | 2015-04-13 | 2020-08-01 | 美商輝瑞股份有限公司 | 靶向b細胞成熟抗原之嵌合型抗原受體類 |
| WO2018170506A1 (en) * | 2017-03-17 | 2018-09-20 | University Of Tennessee Research Foundation | Methods of using cytotoxic t cells for treatment of autoimmune diseases |
| GB201709203D0 (en) | 2017-06-09 | 2017-07-26 | Autolus Ltd | Antigen-binding domain |
| CN111315769A (zh) * | 2017-09-06 | 2020-06-19 | 加州理工学院 | 信号传导和抗原呈递双功能受体(sabr) |
| GB201716728D0 (en) * | 2017-10-12 | 2017-11-29 | Autolus Ltd | Cell |
| CA3082204A1 (en) * | 2017-12-13 | 2019-06-20 | Janssen Biotech, Inc. | Immortalized car-t cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expression |
| WO2019210280A1 (en) * | 2018-04-27 | 2019-10-31 | Casebia Therapeutics Limited Liability Partnership | Anti-bcma car-t-cells for plasma cell depletion |
| WO2019210281A1 (en) * | 2018-04-27 | 2019-10-31 | Casebia Therapeutics Limited Liability Partnership | Methods and compositions of cytotoxic t cell depletion |
| WO2019220109A1 (en) | 2018-05-15 | 2019-11-21 | Autolus Limited | Chimeric antigen receptor |
| SG11202102781UA (en) | 2018-09-27 | 2021-04-29 | Autolus Ltd | Chimeric antigen receptor |
| GB201817822D0 (en) | 2018-10-31 | 2018-12-19 | Autolus Ltd | Binding domain |
| EP3947647A4 (en) * | 2019-03-29 | 2023-01-04 | Board of Regents, The University of Texas System | METHODS OF MANUFACTURE OF CAR NK CELLS AND USE THEREOF |
-
2020
- 2020-04-08 GB GBGB2005216.3A patent/GB202005216D0/en not_active Ceased
-
2021
- 2021-04-08 JP JP2022559575A patent/JP2023520205A/ja active Pending
- 2021-04-08 CN CN202180024674.3A patent/CN115348869A/zh active Pending
- 2021-04-08 US US17/915,737 patent/US20230338534A1/en not_active Abandoned
- 2021-04-08 EP EP21719219.4A patent/EP4132566A1/en active Pending
- 2021-04-08 US US17/915,802 patent/US20230148144A1/en not_active Abandoned
- 2021-04-08 WO PCT/GB2021/050863 patent/WO2021205173A1/en not_active Ceased
- 2021-04-08 WO PCT/GB2021/050862 patent/WO2021205172A1/en not_active Ceased
- 2021-04-08 EP EP21719220.2A patent/EP4132567A1/en active Pending
- 2021-04-08 CA CA3174659A patent/CA3174659A1/en active Pending
- 2021-04-08 AU AU2021251459A patent/AU2021251459A1/en active Pending
-
2025
- 2025-05-02 JP JP2025076879A patent/JP2025107358A/ja active Pending
- 2025-05-16 JP JP2025082745A patent/JP2025122064A/ja active Pending
-
2026
- 2026-01-26 US US19/459,793 patent/US20260224627A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220281944A1 (en) | Spycatcher and spytag: universal immune receptors for t cells | |
| Govers et al. | T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing | |
| US12161668B2 (en) | T cells expressing a chimeric antigen receptor | |
| JP7566628B2 (ja) | キメラ抗原受容体を発現する免疫細胞 | |
| US20170342124A1 (en) | Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens | |
| JP2023506184A (ja) | Lilrb1ベースのキメラ抗原受容体 | |
| CA3125345A1 (en) | Anti-tcr antibody molecules and uses thereof | |
| JP2019525771A5 (cg-RX-API-DMAC7.html) | ||
| IL277398B2 (en) | Pd-l1 binding affimers, and uses related thereto | |
| JP2021529559A (ja) | グルコース輸入を向上させるトランス代謝分子と組み合わせたキメラ受容体及びその治療的使用 | |
| JP7723420B2 (ja) | B細胞標的化並列CAR(pCAR)治療的薬剤 | |
| CN108513576A (zh) | 可调变体免疫球蛋白超家族结构域和工程改造的细胞治疗 | |
| CA3002751A1 (en) | Methods for culturing cells and kits and apparatus for same | |
| RU2018109426A (ru) | Химерные антигенные рецепторы со встроенными контролируемыми функциями | |
| RU2020109577A (ru) | Клетка | |
| Kwong et al. | Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity | |
| JP2022527162A5 (cg-RX-API-DMAC7.html) | ||
| US12534509B2 (en) | Engineered immune cells with receptor cross-talk | |
| CN115348869A (zh) | 细胞 | |
| NO313883B1 (no) | Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18 | |
| JP2025524457A (ja) | 哺乳動物におけるキメラ抗原受容体介在性の免疫応答を刺激するための方法において使用するためのcd123に対する標的化モジュール | |
| TH1801006163A (th) | ไคเมอริกรีเซพเตอร์ให้แก่ flt3 และวิธีการใช้สิ่งดังกล่าว |